24.205
-0.655 (-2.63%)
-0.655 (-2.63%)
Upgrade to Real-Time
Regular Market
Low
23.7899
High
67.74
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioXcel Therapeutics Inc | BTAI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.655 | -2.63% | 24.205 | 12:42:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 24.64 | 23.7899 | 24.85 | 24.86 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 24.12 | 24.21 | 0.09 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,674 | 235,189 | $ 24.25 | $ 5,703,214 | - | 23.7899 - 67.74 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:42:26 | 5 | $ 24.2146 | USD |
Period:
Draw Mode:
BioXcel Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 672.58M | 27.79M | 18.30M | $ - | $ - | -3.77 | -6.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.84M | 0.80% |
BioXcel Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTAI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 26.615 | 27.95 | 23.7899 | 26.46 | 296,936 | -2.41 | -9.06% |
| 1 Month | 31.50 | 32.09 | 23.7899 | 27.98 | 480,110 | -7.30 | -23.16% |
| 3 Months | 34.35 | 38.9994 | 23.7899 | 31.09 | 399,379 | -10.15 | -29.53% |
| 6 Months | 49.87 | 67.74 | 23.7899 | 39.96 | 457,448 | -25.67 | -51.46% |
| 1 Year | 61.50 | 67.74 | 23.7899 | 43.86 | 512,264 | -37.30 | -60.64% |
| 3 Years | 10.09 | 74.89 | 2.41 | 36.70 | 316,672 | 14.12 | 139.89% |
| 5 Years | 11.02 | 74.89 | 2.41 | 35.96 | 289,185 | 13.19 | 119.65% |
BioXcel Therapeutics Description
| BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. |
